Loyal Valley Capital
Shanghai, Shanghailoyalvalleycapital.com
Overview
Loyal Valley Capital is a thematic, research-driven private equity firm with a strong entrepreneurial culture that invests in companies positioned to benefit from the secular industry transformations in China. The firm mainly focuses on three key sectors: New Consumer, Healthcare, and Advanced Manufacturing. LVC manages capital on behalf of international institutional investors such as sovereign wealth funds, funds of funds, private banks, and family offices, as well as elite entrepreneurs and founders of China's Fortune 500 enterprises.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Vivacta Biotechnology (Shanghai) Co., Ltd. | Apr 2026 | Series A | Lead |
| Galaxea AI | Feb 2026 | Series B | Co-investor |
| Beijing Surgerii Robotics | Dec 2025 | Series D | Lead |
| DPTechnology | Aug 2023 | Series C | Co-investor |
| Chibaidao | Jun 2023 | Follow-on Offering | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.